清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY

奎硫平 多导睡眠图 安慰剂 心理学 临床全球印象 简明精神病评定量表 富马酸奎硫平 睡眠开始 麻醉 评定量表 失眠症 非定型抗精神病薬 医学 精神科 精神病 精神分裂症(面向对象编程) 抗精神病药 呼吸暂停 发展心理学 病理 替代医学
作者
Hubert H. Fernandez,Michael S. Okun,Ramon L. Rodriguez,Irene A. Malaty,Janet Romrell,Anqi Sun,Samuel S. Wu,SANDEEP PILLARISETTY,ANAND NYATHAPPA,Stephan Eisenschenk
出处
期刊:International Journal of Neuroscience [Informa]
卷期号:119 (12): 2196-2205 被引量:106
标识
DOI:10.3109/00207450903222758
摘要

Polysomnographic studies of Parkinson's disease (PD) patients with visual hallucinations (VH) usually reveal short, fragmented rapid eye movement (REM) sleep, with lower sleep efficiency and reduced total REM sleep. Quetiapine has been demonstrated in open-label trials to be effective for the treatment of insomnia and VH in PD. To confirm quetiapine's efficacy in improving VH, and to determine whether the mechanism was due to its effect on REM sleep architecture, we performed a pilot, double-blind, placebo-controlled study. Sixteen PD patients experiencing VH were recruited. Eight patients were randomized to quetiapine and eight patients to placebo. Patients underwent pre- and post-treatment polysomnography. The Clinical Global Impression Scale (CGIS), Brief Psychiatric Rating Scale (BPRS), and Unified Parkinson Disease Rating Scale (UPDRS) motor subscale were obtained. There were no differences in baseline characteristics between the treatment arms except that the placebo group had more sleep in stage REM (74.7 min vs. 40.1 min; p < .001). Data were imputed for all patients who prematurely discontinued (four quetiapine and one placebo) in an intention-to-treat analysis. The average quetiapine dose was 58.3 mg/day. While there was no significant difference in the change in REM duration pre- vs. post-treatment in either arm, patients randomized to quetiapine improved on the CGIS (p = .03) and the hallucination item of the BPRS (p = .02). No difference was noted in the UPDRS motor scores. Despite the small sample, this is the first double-blind trial to show quetiapine's efficacy over placebo in controlling VH in the PD population. However, normalization of sleep architecture was not supported as the mechanism.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可夫司机完成签到 ,获得积分10
6秒前
wushuimei完成签到 ,获得积分10
7秒前
娇娇大王完成签到,获得积分10
7秒前
keyanzhang完成签到 ,获得积分0
9秒前
skp完成签到,获得积分10
13秒前
隐形曼青应助hk1900采纳,获得10
19秒前
宗嘻嘻完成签到 ,获得积分10
21秒前
华仔应助龙猫爱看书采纳,获得10
22秒前
美好乐松应助科研通管家采纳,获得10
23秒前
科研通AI2S应助科研通管家采纳,获得10
23秒前
spark810应助科研通管家采纳,获得30
23秒前
风秋杨完成签到 ,获得积分10
32秒前
33秒前
38秒前
糊涂的青烟完成签到 ,获得积分10
43秒前
爱听歌的大地完成签到 ,获得积分10
53秒前
苗笑卉发布了新的文献求助10
54秒前
kais完成签到 ,获得积分10
1分钟前
胖胖橘完成签到 ,获得积分10
1分钟前
CGFHEMAN完成签到 ,获得积分10
1分钟前
毛毛弟完成签到 ,获得积分10
1分钟前
1分钟前
Zeeki完成签到 ,获得积分10
1分钟前
mm_zxh完成签到,获得积分10
1分钟前
1分钟前
哭泣的幻翠完成签到 ,获得积分10
1分钟前
好名字完成签到,获得积分10
1分钟前
回首不再是少年完成签到,获得积分0
1分钟前
聪明的鹤完成签到 ,获得积分10
1分钟前
1分钟前
闪闪的谷梦完成签到 ,获得积分10
2分钟前
Yolenders完成签到 ,获得积分10
2分钟前
丰富的绮山完成签到,获得积分10
2分钟前
默11完成签到 ,获得积分10
2分钟前
积极冷松完成签到 ,获得积分10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
spark810应助科研通管家采纳,获得30
2分钟前
ee_Liu完成签到,获得积分10
2分钟前
锅包肉完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3081598
求助须知:如何正确求助?哪些是违规求助? 2734439
关于积分的说明 7532820
捐赠科研通 2383917
什么是DOI,文献DOI怎么找? 1264125
科研通“疑难数据库(出版商)”最低求助积分说明 612563
版权声明 597578